"10.1371_journal.pone.0021305","plos one","2011-06-23T00:00:00Z","Lena Bengestrate; Sam Virtue; Mark Campbell; Antonio Vidal-Puig; Dirk Hadaschik; Peter Hahn; Wolfgang Bielke","Department of Epigenetics, QIAGEN GmbH, Hilden, Germany; Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom","Conceived and designed the experiments: LB SV MC AV-P DH PH WB. Performed the experiments: LB SV MC PH. Analyzed the data: LB SV MC AV-P DH PH WB. Contributed reagents/materials/analysis tools: SV MC AV-P. Wrote the paper: LB PH DH WB.","The authors DH, PH, and WB are currently employees within the R&D department of QIAGEN GmbH and declare potential competing financial interests, including personal ownership of QIAGEN stocks and/or stock options. Several commercially available products, marketed by QIAGEN, were employed for this study. These products include kits and items for nucleic acid isolation and amplification, as well as the miScript system for microRNA detection. QIAGEN holds several issued and pending patents related to these products. The above said does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.","2011","06","Lena Bengestrate","LB",7,TRUE,7,4,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
